Status

PDF |Add To My Favorites |Track Bill | print page

AB-715 Workgroup review of opioid pain reliever use and abuse.(2017-2018)

Senate:1stCmt2nd3rdPass
Assembly:1stCmt2nd3rdPassPassVeto
Bill Status
AB-715
Wood (A)
-
-
Workgroup review of opioid pain reliever use and abuse.
03/18/17
An act to add and repeal Part 6.3 (commencing with Section 1179.90) of Division 1 of the Health and Safety Code, relating to public health.
Assembly
09/13/17
06/08/17

Type of Measure
Inactive Bill - Vetoed
Majority Vote Required
Non-Appropriation
Fiscal Committee
Non-State-Mandated Local Program
Non-Urgency
Non-Tax levy
Last 5 History Actions
Date Action
10/09/17 Vetoed by Governor.
09/19/17 Enrolled and presented to the Governor at 3 p.m.
09/11/17 Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 77. Noes 0. Page 3108.).
09/06/17 In Assembly. Concurrence in Senate amendments pending. May be considered on or after September 8 pursuant to Assembly Rule 77.
09/06/17 Read third time. Passed. Ordered to the Assembly. (Ayes 40. Noes 0. Page 2506.).
Governor's Veto Message
To the Members of the California State Assembly:

I am returning Assembly Bill 715 without my signature.

This bill requires the Department of Public Health to convene a workgroup to develop a statewide guideline for prescribing opioids for acute, short term pain.

Opioid misuse and addiction is a national epidemic that has been devastating for many California communities. Since 2014, the Department of Public Health has lead the Prescription Opioid Misuse and Overdose Prevention Workgroup which is comprised of state and local agencies as well as medical and patient organizations committed to reducing opioid overdose rates in California. Furthermore, both the California Medical Board and the federal Centers for Disease Control have published updated guidelines for prescribing controlled substances for pain including opioids. For these reasons, this bill is unnecessary.

Sincerely,



Edmund G. Brown Jr.